News
The latest news and updates from Cerulea – from new research advances to stories of the real-life impact of our research.
Feature stories
Cerulea to welcome Dr Michelle Bradney as new CEO
Cerulea Clinical Trials has appointed senior pharmaceutical and biotechnology executive Dr Michelle Bradney as its new Chief Executive Officer.
Cerulea Clinical Trials’ newly appointed interim CEO is an experienced healthcare leader – bringing deep experience in the pharmaceutical, biotech and clinical research industries.
Cerulea Clinical Trials, launched today in Melbourne, will bring more international trials to Victoria and give people living with vision loss and blindness early access to sight-saving therapies.